Yenssen Biotech

Jiangsu Yenssen Biotech Co., Ltd. is a specialized medical technology company founded in 2003 and headquartered in Jiangyin, China. The company focuses on the research, development, and production of advanced biomaterials for tissue repair and regeneration. Its core product portfolio includes Dermlin for chronic and acute wound healing, Osteobone for bone defect restoration, and Ulceloocin for treating oral ulcers. Yenssen Biotech utilizes proprietary inorganic bioactive materials that facilitate natural healing processes without the need for antibiotics or biological agents. The company maintains GMP-compliant manufacturing facilities and has achieved multiple international certifications, including US FDA and CE marks, supporting its distribution across global markets.